Why the study?
While ePWV is recognized as a cardiovascular risk marker, evidence evaluating its associations with prevalent ASCVD and mortality outcomes in U.S. adults remained limited.
Is higher estimated pulse wave velocity associated with prevalent ASCVD and increased mortality in U.S. adults?
Population
34,200 adults aged ≥20 years in NHANES 2001-2018
Comparison
Higher vs lower ePWV levels
Design
Nationally representative observational cohort study
Key result
Higher estimated pulse wave velocity was significantly associated with prevalent ASCVD (OR 1.21; 95% CI 1.13-1.31; P<0.0001) as well as increased all-cause and cardiovascular mortality.
Authors
Loading...
ePWV may mark vascular aging in U.S. adults; hypothesis-generating for prospective validation before risk-stratification use.
Observational (n=34,200)
Is higher estimated pulse wave velocity associated with prevalent ASCVD and increased mortality in U.S. adults?
Effect estimate: OR 1.21 (95% CI 1.13-1.31)
p-value: p=<0.0001
Higher estimated pulse wave velocity is strongly associated with prevalent ASCVD and increased risk of all-cause and cardiovascular mortality in U.S. adults, supporting its utility as a marker of vascular aging.
Wu et al. (2026) conducted an observational in Atherosclerotic cardiovascular disease (n=34,200). Estimated pulse wave velocity (ePWV) was evaluated on Prevalent ASCVD (OR 1.21, 95% CI 1.13-1.31, p=<0.0001). Higher estimated pulse wave velocity was significantly associated with prevalent ASCVD (OR 1.21; 95% CI 1.13-1.31; P<0.0001) as well as increased all-cause and cardiovascular mortality.